California State Teachers Retirement System (CalSTRS)’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,854
Closed -$59K 3037
2019
Q1
$59K Sell
2,854
-684
-19% -$13.6K ﹤0.01% 2954
2018
Q4
$57K Buy
3,538
+685
+24% +$32.1K ﹤0.01% 2975
2018
Q3
$263K Hold
2,853
﹤0.01% 2768
2018
Q2
$457K Buy
2,853
+722
+34% +$122K ﹤0.01% 2494
2018
Q1
$343K Sell
2,131
-42
-2% -$5.12K ﹤0.01% 2567
2017
Q4
$228K Sell
2,173
-56
-3% -$6.01K ﹤0.01% 2788
2017
Q3
$292K Sell
2,229
-211
-9% -$25.8K ﹤0.01% 2699
2017
Q2
$333K Buy
2,440
+1,120
+85% +$134K ﹤0.01% 2701
2017
Q1
$157K Buy
1,320
+187
+17% +$22.1K ﹤0.01% 2868
2016
Q4
$152K Sell
1,133
-34
-3% -$8.53K ﹤0.01% 2909
2016
Q3
$304K Buy
+1,167
New +$143K ﹤0.01% 2740

Other funds holding CLSD

California State Teachers Retirement System (CalSTRS)'s CLSD Position: Q2 2019 in Review

California State Teachers Retirement System (CalSTRS) sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 2,854 shares — an estimated $59K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CLSD in Q3 2016 and held it in 11 quarters. The position peaked at $457K in Q2 2018. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 2,854 Clearside Biomedical shares in Q2 2019, an estimated $59K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Clearside Biomedical in Q3 2016 and held it in 11 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Clearside Biomedical position peaked at $457K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2019, filed 14 Aug 2019.